Extracorporeal Membrane Oxygenation Ecmo Machine Market
PUBLISHED: 2023 ID: SMRC23316
SHARE
SHARE

Extracorporeal Membrane Oxygenation Ecmo Machine Market

Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecasts to 2030 - Global Analysis By Product (Portable Devices, Static Devices, Software and Other Products), Component (Pumps, Oxygenators, Controllers, Cannula and Other Components), Modality, Patient Type, Application and By Geography

4.3 (48 reviews)
4.3 (48 reviews)
Published: 2023 ID: SMRC23316

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2021-2030

Estimated Year Value (2023)

US $608.37 MN

Projected Year Value (2030)

US $989.76 MN

CAGR (2023 - 2030)

7.2%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

North America


According to Stratistics MRC, the Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market is accounted for $608.37 million in 2023 and is expected to reach $989.76 million by 2030 growing at a CAGR of 7.2% during the forecast period. Extracorporeal membrane oxygenation is a type of life-supporting technology used for individuals with severe, terminal illnesses that impair their heart's or lungs' ability to function normally and keep them from breathing normally. In addition to helping those awaiting a heart or lung transplant, this mechanism offers heart-lung bypass support. Depending on the patient's medical state, ECMO machine support may be given for a short period of time—a few hours or days—or it may last for a few weeks.

According to the Extracorporeal Life Support Organization, in January 2016, around 8,102 children suffered from cardiac illness and required ECMO therapy.



Market Dynamics:

Driver:

Increasing use of ECMO in lung transplant procedures

The need for lung transplants has grown over the forecast period, particularly for the treatment of terminal lung conditions such as cystic fibrosis, Interstitial Lung Disease, and Chronic Obstructive Pulmonary Disease (COPD). Primary Graft Dysfunction (PGD) after lung transplantation is the most frequent cause for the use of ECMO. Lung damage that occurs within the first 72 hours after a lung transplant is known as PGD syndrome. The use of ECMO as a bridging method as a treatment for patients with PGD post-transplant has produced promising results in various studies thanks to considerable technological advancements. The use of ECMO is anticipated to increase further due to the rising prevalence of lung disorders worldwide.

Restraint:

High cost of ECMO products

ECMO is an expensive medical procedure. In addition to the expenditures related to the systems, there are other charges such as hospital lodging and extra disposable accessories. The cost of the treatment increases with the need for a large medical staff to care for the patient receiving an ECMO procedure, although the cost varies depending on how long it is used. The typical hospital stay for a patient receiving ECMO support is between one and two weeks, though it might vary depending on how serious the patient's condition is and last longer. The majority of patients cannot afford the procedure's higher overall cost as a result.

Opportunity:

Increasing survival rates with ECMO

Patients with potentially reversible respiratory failure, such as those with severe acute respiratory distress syndrome (ADRS), primary graft dysfunction following lung transplantation, and lung injury, should be treated with VV-ECMO. Patients with respiratory failure who receive VV-ECMO have a higher survival rate. Due to their capability to support failing circulatory systems with oxygenation functions, ECMO machines are also used in cardiac applications. The survival rates of cardiac patients who use these systems for heart failure are increased.

Threat:

Lack of skilled professionals

ECMO is a highly specialized and complex therapy that requires a team of trained healthcare professionals, including perfusionists, intensivists, nurses, and respiratory therapists, who possess the expertise to operate and manage ECMO machines effectively. However, the limited availability of trained professionals with ECMO-specific knowledge and skills poses challenges to the broader adoption and utilization of ECMO therapy. The lack of skilled professionals in ECMO not only affects the delivery of therapy but also impedes the expansion of ECMO programs and the establishment of new ECMO centers. Without a sufficient number of trained professionals, healthcare facilities may be hesitant to invest in ECMO machines or expand their ECMO services, fearing inadequate staffing and compromised patient care.

Covid-19 Impact:

The COVID-19 pandemic has significantly changed the landscape of healthcare practices worldwide and resulted in considerably high growth of the extracorporeal membrane oxygenation machine market in 2020. This is attributed to the vast spread of the virus and the increasing need for these machines to provide circulatory support and save lives. The improved machine outcome in COVID-19 patients led to increased adoption of these machines in hospitals, thereby fueling the demand for extracorporeal membrane oxygenation machines. Owing to the rise in demand, market players witnessed increased demand for their products during the pandemic.

The pumps segment is expected to be the largest during the forecast period

The pumps segment also has a considerable market share owing to its high cost and usage. The ECMO machines' pumps assist in moving a patient's blood through artificial lungs for oxygenation before returning the blood to the patient. Due to the widespread use of pumps in ECMO treatments and the accessibility of many types of pumps, including roller, impeller, and centrifugal pumps, the segment has experienced significant expansion. According to their requirements, these pumps are employed in a variety of ECMO procedures, which will fuel the market expansion of this sector throughout the forecasted time.

The respiratory segment is expected to have the highest CAGR during the forecast period

The respiratory segment has the highest CAGR in the market over the forecast period. The market is expanding due to the rapid spread of the target diseases, the limited availability of early diagnosis and medical testing, and technological developments in the Extracorporeal Membrane Oxygenation Machine Market. Diagnostic medical imaging is also expanding due to the rising incidence of respiratory diseases like tuberculosis, thorax malignant neoplasms, osteoporosis, broken bones, and CVD risk factors, which will propel the segment's growth.

Region with highest share:

North America dominated the market over the forecast period. North America is a significant market for Extracorporeal Membrane Oxygenation (ECMO) Machines, with several prominent players operating in the region. The growth of this market in the region can be attributed to the government support for quality healthcare, high purchasing power parity, and the increasing prevalence of diseases such as chronic obstructive pulmonary disease in the U.S. and Canada. The presence of sophisticated healthcare facilities and favorable reimbursement policies has led to an increased hospital admission rate which in turn is expected to boost the usage rates in this region.

Region with highest CAGR:

During the forecast period, the Asia Pacific market is anticipated to grow at the fastest rate. The rising geriatric population, especially in Japan, rising disposable incomes, making more advanced technologies affordable, the rising prevalence of target diseases, and supportive government initiatives are the main drivers of the ECMO machine market's growth in the Asia Pacific region. These elements propel the regional market for digital imaging equipment and draw in collaborations and investments from abroad. On the other hand, the expansion of the market in the Asia Pacific is being somewhat constrained by low hospital budgets, expensive equipment costs, and a lack of government expenditures in some nations.



Key players in the market

Some of the key players in Extracorporeal Membrane Oxygenation (ECMO) Machine Market include ABIOMED, EUROSETS, Getinge AB, LivaNova PLC, MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Medtronic, Microport Scientific Corporation, Nipro Medical Corporation, Sorin Group, Spectrum Medical, Terumo Cardiovascular Systems Corporation and Xenios AG.

Key Developments:

In May 2022, MicroPort Scientific Corporation acquired Hemovent GmbH and Hemovent GmbH's MOBYBOX ECMO System for the Treatment of COVID-19 Patients Published in Leading International Medical Journal-ASAIO Journal

In November 2022, LivaNova PLC announced the FDA clearance for LifeSPARC. The company received 510(k) approval for its next-generation advanced circulatory support system

In October 2021, MicroPort Scientific Corporation acquired German Extracorporeal life support (ECLS) company Hemovent GmbH and invested in expanding the company’s German operations

In July 2021, Xenios AG received approval from the National Medical Products Administration (NMPA) in China for the Xenios Console and patient kits for ECMO therapy

Products Covered:
• Portable Devices
• Static Devices
• Software
• Other Products

Components Covered:
• Pumps
• Oxygenators
• Controllers
• Cannul a
• Breathing Accessories
• Other Components

Modalities Covered:
• Veno-Venous
• Veno-Arterials
• Arterio-Venous
• Other Modalities

Patient Types Covered:
• Neonates
• Pediatrics
• Adults

Applications Covered:
• Respiratory
• Cardiac
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)
• Cardiopulmonary Resuscitation (CPR)
• Congenital Heart Defects
• Bridge to Transplantation
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026 and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market, By Product
5.1 Introduction
5.2 Portable Devices
5.3 Static Devices
5.4 Software
5.5 Other Products

6 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market, By Component
6.1 Introduction
6.2 Pumps
6.3 Oxygenators
6.4 Controllers
6.5 Cannula
6.6 Breathing Accessories
6.7 Other Components

7 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market, By Modality
7.1 Introduction
7.2 Veno-Venous
7.3 Veno-Arterials
7.4 Arterio-Venous
7.5 Other Modalities

8 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market, By Patient Type
8.1 Introduction
8.2 Neonates
8.3 Pediatrics
8.4 Adults

9 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market, By Application
9.1 Introduction
9.2 Respiratory
9.3 Cardiac
9.4 Extracorporeal cardiopulmonary resuscitation (ECPR)
9.5 Cardiopulmonary Resuscitation (CPR)
9.6 Congenital Heart Defects
9.7 Bridge to Transplantation
9.8 Other Applications

10 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 ABIOMED
12.2 EUROSETS
12.3 Getinge AB
12.4 LivaNova PLC
12.5 MAQUET Holding B.V. & Co. KG
12.6 Medos Medizintechnik AG
12.7 Medtronic
12.8 Microport Scientific Corporation
12.9 Nipro Medical Corporation
12.10 Sorin Group
12.11 Spectrum Medical
12.12 Terumo Cardiovascular Systems Corporation
12.13 Xenios AG

List of Tables
1 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Region (2021-2030) ($MN)
2 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Product (2021-2030) ($MN)
3 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Portable Devices (2021-2030) ($MN)
4 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Static Devices (2021-2030) ($MN)
5 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Software (2021-2030) ($MN)
6 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Other Products (2021-2030) ($MN)
7 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Component (2021-2030) ($MN)
8 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Pumps (2021-2030) ($MN)
9 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Oxygenators (2021-2030) ($MN)
10 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Controllers (2021-2030) ($MN)
11 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Cannula (2021-2030) ($MN)
12 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Breathing Accessories (2021-2030) ($MN)
13 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Other Components (2021-2030) ($MN)
14 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Modality (2021-2030) ($MN)
15 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Veno-Venous (2021-2030) ($MN)
16 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Veno-Arterials (2021-2030) ($MN)
17 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Arterio-Venous (2021-2030) ($MN)
18 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Other Modalities (2021-2030) ($MN)
19 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Patient Type (2021-2030) ($MN)
20 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Neonates (2021-2030) ($MN)
21 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Pediatrics (2021-2030) ($MN)
22 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Adults (2021-2030) ($MN)
23 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Application (2021-2030) ($MN)
24 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Respiratory (2021-2030) ($MN)
25 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Cardiac (2021-2030) ($MN)
26 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Extracorporeal cardiopulmonary resuscitation (ECPR) (2021-2030) ($MN)
27 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Cardiopulmonary Resuscitation (CPR) (2021-2030) ($MN)
28 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
29 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Bridge to Transplantation (2021-2030) ($MN)
30 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials